Patent applications and USPTO patent grants for ENDO PHARMACEUTICALS INC..The latest application filed is for "oxymorphone controlled release compositions".
Patent | Date |
---|---|
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 11,389,443 - Ahdieh July 19, 2 | 2022-07-19 |
Oxymorphone Controlled Release Compositions App 20210008063 - Kao; Huai-Hung ;   et al. | 2021-01-14 |
Sustained release formulations of nalbuphine Grant 10,406,106 - Baichwal , et al. Sept | 2019-09-10 |
Vitamin B12 Nasal Spray And Method Of Use App 20190216842 - FELLER; Theodore H. ;   et al. | 2019-07-18 |
Sustained Release Formulations Of Nalbuphine App 20190117576 - BAICHWAL; Anand R. ;   et al. | 2019-04-25 |
Vitamin B.sub.12 nasal spray and method of use Grant 10,251,908 - Feller , et al. | 2019-04-09 |
Sustained release formulation of nalbuphine Grant 10,172,798 - Baichwal , et al. J | 2019-01-08 |
Oxymorphone Controlled Release Compositions App 20180338967 - Kao; Huai-Hung ;   et al. | 2018-11-29 |
Vitamin B.sub.12 nasal spray and method of use Grant 10,052,344 - Feller , et al. August 21, 2 | 2018-08-21 |
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20180098985 - Ahdieh; Harry | 2018-04-12 |
Crystalline, anhydrous forms of oxymorphone hydrochloride Grant 9,926,328 - Fischer , et al. March 27, 2 | 2018-03-27 |
Sustained Release Formulation Of Nalbuphine App 20180042852 - BAICHWAL; Anand R. ;   et al. | 2018-02-15 |
Oxymorphone controlled release formulations Grant 9,820,982 - Kao , et al. November 21, 2 | 2017-11-21 |
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 9,789,103 - Ahdieh October 17, 2 | 2017-10-17 |
Crystalline, Anhydrous Forms Of Oxymorphone Hydrochloride App 20170137433 - FISCHER; Andreas ;   et al. | 2017-05-18 |
Sustained Release Formulation Of Nalbuphine App 20160263035 - BAICHWAL; Anand R. ;   et al. | 2016-09-15 |
Crystalline, anhydrous forms of oxymorphone hydrochloride Grant 9,440,986 - Fischer , et al. September 13, 2 | 2016-09-13 |
Sustained release formulation of nalbuphine Grant 9,351,938 - Baichwal , et al. May 31, 2 | 2016-05-31 |
Oxymorphone Controlled Release Compositions App 20160136152 - Kao; Huai-Hung ;   et al. | 2016-05-19 |
Urethral Anastomosis Device And Method App 20160074041 - Wirtel, III; Anthony J. | 2016-03-17 |
Chronotherapeutic dosage forms Grant 9,278,076 - Baichwal , et al. March 8, 2 | 2016-03-08 |
Sustained release formulation of nalbuphine Grant 9,186,330 - Baichwal , et al. November 17, 2 | 2015-11-17 |
Urethral Anastomosis Device And Method App 20150250479 - Goldberg; Roger P. ;   et al. | 2015-09-10 |
Urethral Anastomosis Device And Method App 20150245839 - Wirtel, III; Anthony J. ;   et al. | 2015-09-03 |
Urethral anastomosis device and method Grant 9,050,163 - Goldberg , et al. June 9, 2 | 2015-06-09 |
Oxymorphone Controlled Release Formulations App 20150011577 - Kao; Huai-Hung ;   et al. | 2015-01-08 |
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20140329847 - Ahdieh; Harry | 2014-11-06 |
Sustained Release Formulation Of Nalbuphine App 20140315937 - Baichwal; Anand R. ;   et al. | 2014-10-23 |
Method of treating pain utilizing controlled release oxymorphone pharmaceutical compositions and instruction on dosing for renal impairment Grant 8,808,737 - Ahdieh August 19, 2 | 2014-08-19 |
Pyridine derivatives Grant 8,809,372 - Smith , et al. August 19, 2 | 2014-08-19 |
Pyrimido-pyridazinone Compounds And Methods Of Use Thereof App 20140221315 - Venkatesan; Aranapakam ;   et al. | 2014-08-07 |
Cyclohexylamines App 20140213552 - Thompson; Scott Kevin ;   et al. | 2014-07-31 |
Sustained release formulations of nalbuphine Grant 8,771,732 - Baichwal , et al. July 8, 2 | 2014-07-08 |
Sustained release formulation of nalbuphine Grant 8,765,175 - Baichwal , et al. July 1, 2 | 2014-07-01 |
Pyrimido-pyridazinone compounds and methods of use thereof Grant 8,729,079 - Venkatesan , et al. May 20, 2 | 2014-05-20 |
Oxymorphone Controlled Release Formulations App 20140134250 - Kao; Huai-Hung ;   et al. | 2014-05-15 |
Cyclohexylamines Grant 8,685,418 - Thompson , et al. April 1, 2 | 2014-04-01 |
Sustained release matrix systems for highly soluble drugs Grant 8,679,535 - Baichwal , et al. March 25, 2 | 2014-03-25 |
Substituted Quinazoline and Pyrido-Pyrimidine Derivatives App 20140073782 - Smith; Roger A. ;   et al. | 2014-03-13 |
Use of Aminoindane Compounds in Treating Overactive Bladder and Interstitial Cystitis App 20140051702 - Gupta; Sandeep ;   et al. | 2014-02-20 |
Substituted Amino-Pyrimidine Derivatives App 20140038952 - Smith; Roger Astbury ;   et al. | 2014-02-06 |
Catheter Valve And Methods Of Using Same App 20130324975 - Douglas; Peter F. ;   et al. | 2013-12-05 |
Abuse-resistant Opioid Dosage Form App 20130209561 - Kao; Huai-Hung ;   et al. | 2013-08-15 |
Substituted Quinazoline And Pyrido-pyrimidine Derivatives App 20130190492 - Smith; Roger Astbury ;   et al. | 2013-07-25 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20130172382 - Caruso; Frank S. ;   et al. | 2013-07-04 |
Substituted quinazoline and pyrido-pyrimidine derivatives Grant 8,440,662 - Smith , et al. May 14, 2 | 2013-05-14 |
Cyclohexylamines App 20130101667 - Thompson; Scott Kevin ;   et al. | 2013-04-25 |
Imidazole Derivatives App 20130085164 - Smith; Roger Astbury ;   et al. | 2013-04-04 |
Pyridine Derivatives App 20130085148 - Smith; Roger Astbury ;   et al. | 2013-04-04 |
Pyrimido-pyridazinone Compounds And Methods Of Use Thereof App 20130053346 - Venkatesan; Aranapakam ;   et al. | 2013-02-28 |
Oxymorphone controlled release formulations Grant 8,329,216 - Kao , et al. December 11, 2 | 2012-12-11 |
Oxymorphone controlled release formulations Grant 8,309,122 - Kao , et al. November 13, 2 | 2012-11-13 |
Abuse-resistant Controlled-release Opioid Dosage Form App 20120252832 - Caruso; Frank S. ;   et al. | 2012-10-04 |
Urethral Anastomosis Device And Method App 20120245606 - Goldberg; Roger P. ;   et al. | 2012-09-27 |
Abuse-resistant Opioid Dosage Form App 20120237603 - Kao; Huai-Hung ;   et al. | 2012-09-20 |
Abuse-resistant Opioid Dosage Form App 20120231075 - Kao; Huai-Hung ;   et al. | 2012-09-13 |
Substituted Quinazoline and Pyrido-Pyrimidine Derivatives App 20120129851 - Smith; Roger Astbury ;   et al. | 2012-05-24 |
Abuse-resistant Opioid Dosage Form App 20110135731 - Kao; Huai-Hung ;   et al. | 2011-06-09 |
Abuse-resistant Opioid Dosage Form App 20110020444 - Kao; Huai-Hung ;   et al. | 2011-01-27 |
Method Of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions And Instruction On Dosing For Renal Impairment App 20100151027 - Ahdieh; Harry | 2010-06-17 |
Oxymorphone Controlled Release Formulations App 20090192183 - Kao; Huai-Hung ;   et al. | 2009-07-30 |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol App 20090124650 - Ahdieh; Harry | 2009-05-14 |
Treatment of xerostomia Grant 7,501,452 - Troha , et al. March 10, 2 | 2009-03-10 |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment App 20080318993 - Ahdieh; Harry | 2008-12-25 |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment App 20080318994 - Ahdieh; Harry | 2008-12-25 |
Oxymorphone Controlled Release Formulations App 20080262013 - Kao; Huai-Hung ;   et al. | 2008-10-23 |
Transdermal Delivery Form Disposal Systems and Methods App 20080226702 - Goldberg; Alan Philip | 2008-09-18 |
Abuse-resistant controlled-release opioid dosage form App 20080069881 - Caruso; Frank S. ;   et al. | 2008-03-20 |
Oxymorphone Controlled Release Formulations App 20070134328 - Kao; Huai-Hung ;   et al. | 2007-06-14 |
Treatment of xerostomia App 20070128284 - Troha; Janice Mary ;   et al. | 2007-06-07 |
Method for the treatment of urinary incontinence Grant 7,087,619 - Caruso August 8, 2 | 2006-08-08 |
Method for treating non-neuropathic pain App 20060147510 - Galer; Bradley Stuart | 2006-07-06 |
Carbinols for the treatment of neuropathic dysfunction Grant 6,825,217 - Carliss , et al. November 30, 2 | 2004-11-30 |
Oxymorphone controlled release formulations App 20030157167 - Kao, Huai-Hung ;   et al. | 2003-08-21 |
Oral administration of 6-hydroxy-oxymorphone for use as an analgesic App 20030130297 - Kao, Huai-Hung ;   et al. | 2003-07-10 |
Method for treating non-neuropathic pain App 20030124174 - Galer, Bradley Stuart | 2003-07-03 |
Method for the treatment of urinary incontinence Grant 6,562,835 - Caruso May 13, 2 | 2003-05-13 |
Abuse-resistant controlled-release opioid dosage form App 20030065002 - Caruso, Frank S. ;   et al. | 2003-04-03 |
Abuse resistant pharmaceutical composition containing capsaicin App 20030064122 - Goldberg, Michael ;   et al. | 2003-04-03 |
Abuse-resistant opioid dosage form App 20030004177 - Kao, Huai-Hung ;   et al. | 2003-01-02 |
Anticonvulsant containing composition for treating neuropathic pain Grant 6,406,716 - Caruso , et al. June 18, 2 | 2002-06-18 |
Analgesic drug composition containing a capsaicinoid and potentiator therefor Grant 6,277,398 - Caruso August 21, 2 | 2001-08-21 |
Process for manufacturing paroxetine solid dispersions Grant 5,955,475 - Krape , et al. September 21, 1 | 1999-09-21 |
NCAGE Code | 1DBS1 | ENDO PHARMACEUTICALS, INC. |
CAGE Code | 1DBS1 | ENDO PHARMACEUTICALS, INC. |
S.A.M. Registration | 1DBS1 [178074951] | ENDO PHARMACEUTICALS, INC. |
SEC | 0001531420 | Endo Pharmaceuticals Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.